# Oncolyze, Inc.

Private

New York City, New York  
Healthcare & Life Sciences [https://oncolyze.com/](https://oncolyze.com/)

Last Round

Series A

Aug 4, 2022

Est. Valuation  
$30M

Total Funding Raised  
$300,000

## Company Overview

Oncolyze, Inc. is a biotechnology company developing novel biotherapeutics for the treatment of cancer.

### Sector

Healthcare & Life Sciences

### Verticals

Biotechnology, Drug Discovery

### Business Model

B2B

### Customer Profile

Services & Consulting

### AI Layer

Non-AI

### Keywords

biotechnology, drug discovery, oncology, peptide therapeutics, biotech, targeted therapy, preclinical research, drug development, investigational new drug (IND), orphan drug, biopharma, therapeutic pipeline, drug licensing

## Historical Pricing

Historical view of private secondary pricing and transaction trends.

### Unlock Pricing Charts

### Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

### View Momentum History

## Oncolyze, Inc. Comparables

Compare Oncolyze, Inc. with similar companies based on industry and business-model similarity.

| Company | Similarity | Market Cap |
| --- | --- | --- |
| [A28 Therapeutics](/content/company/a28therapeutics/index.html) | 79% | - |
| [Peptomyc](/content/company/peptomyc/index.html) | 78% | - |
| Lytix Biopharma AS | 73% | - |
| Comparable company | 50% | - |

## Oncolyze, Inc. Funding Rounds

Historical fundraising activity

| Round | Date | Amount Raised | Valuation | Investors | Sources |
| --- | --- | --- | --- | --- | --- |
| Series A | Aug 4, 2022 | - | - | - | - |
| Seed | Jan 1, 2019 | - | - | - | - |

## Key People

Founding team and executive leadership

- **Steve Evans**  
 CEO and Acting Chair  
 [LinkedIn profile](https://www.linkedin.com/in/teban)

- **Alex Stojanovic**  
 Fractional COO  
 [LinkedIn profile](https://www.linkedin.com/in/alexstojanovic)

## Oncolyze, Inc. Investors

Notable investors and investment history

| Investor | Rounds |
| --- | --- |
| [The Naissos Group](/content/investor/naissos/index.html) | Seed |

## Market signals

Structured signals derived from secondary market and firmographic data.

- Apr 16, 2026  
 Monthly visitors increased 113% MoM.

- Aug 4, 2022  
 Closed Series A round at $30M post-money valuation.

## Oncolyze, Inc. Filings

SEC and related filings with document metadata.

| Type | Date | Amount Offered | Amount Sold | Filing | Pages |
| --- | --- | --- | --- | --- | --- |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |

## Frequently Asked Questions

Common questions about Oncolyze, Inc.'s valuation, stock price, and market status.

- Is Oncolyze, Inc. a public or private company?
- What is the current stock price of Oncolyze, Inc.?
- How much is Oncolyze, Inc. worth (valuation)?
- Can I buy Oncolyze, Inc. stock?
- When was Oncolyze, Inc.'s last funding round?
- Who are the main investors in Oncolyze, Inc.?
- Will Oncolyze, Inc. IPO soon?
- How can I track Oncolyze, Inc. secondary market activity?

## Firmographic Details

- **Headquarters**: New York City, New York
- **Employee Range**: 5
- **Year Founded**: 2011
- **Last Funding**: Aug 4, 2022